S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

FULC Fulcrum Therapeutics Inc

9.48

1.07 (12.72%)

Last Updated: 04:11:26

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Jul 2024 to Aug 2024

Click Here for more Fulcrum Therapeutics Charts.

Fulcrum Therapeutics (NASDAQ:FULC)
Historical Stock Chart
From Aug 2023 to Aug 2024

Click Here for more Fulcrum Therapeutics Charts.

Fulcrum Therapeutics Inc News

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 31 July 2024 (7 hours ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 31 July 2024 (7 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 31 July 2024 (7 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 8 July 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 June 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 13 May 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 13 May 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 10 May 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 9 March 2024 (5 months ago) • Edgar (US Regulatory)

More Fulcrum Therapeutics Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions